Authors:
VANDEMERBEL NC
TINKE AP
VANDONGEN WD
OOSTERHUIS B
JONKMAN JHG
LADURE P
PUOZZO C
Citation: Nc. Vandemerbel et al., VALIDATED METHOD FOR THE DETERMINATION OF IDAZOXAN IN HUMAN PLASMA BYLIQUID-CHROMATOGRAPHY WITH TANDEM MASS-SPECTROMETRIC DETECTION, Journal of chromatography B. Biomedical sciences and applications, 708(1-2), 1998, pp. 113-120
Citation: C. Puozzo et al., SUPPORT TO PHASE-II CLINICAL-TRIALS OF ORAL VINORELBINE (VRL, NAVELBLNE((R))) BY POPULATION PHARMACOKINETICS (PKS) - A NEW TOOL TO FOLLOW DRUG-INDUCED TOXICITIES, Annals of oncology, 9, 1998, pp. 655-655
Authors:
DEPREZ D
CHASSARD DD
BAILLE PP
MIGNOT A
UNG HL
PUOZZO C
Citation: D. Deprez et al., WHICH BIOEQUIVALENCE STUDY FOR A RACEMIC DRUG - APPLICATION TO MILNACIPRAN, European journal of drug metabolism and pharmacokinetics, 23(2), 1998, pp. 166-171
Authors:
PUOZZO C
ALBIN H
VINCON G
DEPREZ D
RAYMOND JM
AMOURETTI M
Citation: C. Puozzo et al., PHARMACOKINETICS OF MILNACIPRAN IN LIVER IMPAIRMENT, European journal of drug metabolism and pharmacokinetics, 23(2), 1998, pp. 273-279
Authors:
PUOZZO C
POZET N
DEPREZ D
BAILLE P
UNG HL
ZECH PP
Citation: C. Puozzo et al., PHARMACOKINETICS OF MILNACIPRAN IN RENAL IMPAIRMENT, European journal of drug metabolism and pharmacokinetics, 23(2), 1998, pp. 280-286
Authors:
PUOZZO C
FUMOLEAU P
ADENIS A
ROUSSEAU F
MERROUCHE Y
ROBINET G
SENAC I
MARTY M
Citation: C. Puozzo et al., ABSOLUTE BIOAVAILABILITY AND PHARMACOKINETICS (PK) OF ORAL VINORELBINE (VRL) IN PATIENTS (PTS) WITH SOLID TUMORS, European journal of cancer, 33, 1997, pp. 1118-1118
Authors:
JOLY B
LECUREUR V
PUOZZO C
GUILLOUZO A
FARDEL O
Citation: B. Joly et al., INVOLVEMENT OF P-GLYCOPROTEIN IN AN IN-VITRO BLOOD-BRAIN-BARRIER MODEL, International journal of oncology, 9(5), 1996, pp. 1029-1033
Citation: C. Puozzo et Be. Leonard, PHARMACOKINETICS OF MILNACIPRAN IN COMPARISON WITH OTHER ANTIDEPRESSANTS, International clinical psychopharmacology, 11, 1996, pp. 15-27
Authors:
JOLY B
FARDEL O
CECCHELLI R
CHESNE C
PUOZZO C
GUILLOUZO A
Citation: B. Joly et al., SELECTIVE DRUG TRANSPORT AND P-GLYCOPROTEIN ACTIVITY IN AN IN-VITRO BLOOD-BRAIN-BARRIER MODEL, Toxicology in vitro, 9(4), 1995, pp. 357